This fact sheet provides guidelines on how to use doxy PEP (doxycycline post-exposure prophylaxis) as a preventive measure against sexually transmitted infections (STIs). It outlines proper dosage, timing, and considerations for individuals at risk of exposure to STIs, offering a key resource for enhancing STI prevention strategies.
This fact sheet provides guidelines on how to use doxy PEP (doxycycline post-exposure prophylaxis) as a preventive measure against sexually transmitted infections (STIs). It outlines proper dosage, timing, and considerations for individuals at risk of exposure to STIs, offering a key resource for enhancing STI prevention strategies.
This fact sheet provides guidelines on how to use doxy PEP (doxycycline post-exposure prophylaxis) as a preventive measure against sexually transmitted infections (STIs). It outlines proper dosage, timing, and considerations for individuals at risk of exposure to STIs, offering a key resource for enhancing STI prevention strategies.
This fact sheet provides guidelines on how to use doxy PEP (doxycycline post-exposure prophylaxis) as a preventive measure against sexually transmitted infections (STIs). It outlines proper dosage, timing, and considerations for individuals at risk of exposure to STIs, offering a key resource for enhancing STI prevention strategies.
This guideline outlines the importance of Medicaid 1115 waivers and pre-release healthcare coverage in improving access to hepatitis C (HCV) treatment for incarcerated individuals. It discusses how expanding Medicaid coverage can enhance continuity of care, reduce transmission, and support reentry populations.
The purpose of this Notice of Funding Opportunity (NOFO) is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously funded under the auspices of PAR-21-089 and PAR-18-669 that support Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) research. Breeding colonies are essential to sustain appropriate SPF macaques for research related to HIV/AIDS. Pedigree SPF macaques are free of certain viruses, which may confound the results of HIV/AIDS-related investigations or present a risk to the personnel who care for the animals.
The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use.
This notice of funding opportunity (NOFO) encourages revision applications from currently funded NIH Centers for AIDS Research (CFAR) and Developmental CFARs (D-CFAR) to expand the role of the CFARs and D-CFARs to include additional support and infrastructure for outreach and research related to HIV and HIV-related health disparities in the United States and globally. The goal of the NOFO is aimed towards diversifying and supporting the next generation of HIV/AIDS investigators, and engaging and mentoring these investigators in high-priority HIV/AIDS research.
This NOFO invites applications at the intersection of HIV and aging by proposing research that aims to meet the following objectives: 1) Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) Improve approaches for testing, preventing, and treating HIV infection, and managing HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying current aging science approaches.
